Latest news
-
Smoking Cessation and Nicotine De-addiction Products Market will be Worth US$ 20.5 Billion by 2023
The global smoking cessation and nicotine de-addiction products market was valued at US$ 6.5 Bn in 2014 and is anticipated to expand at a CAGR of 13.7
-
Ultrasonic Electrosurgical Devices Market Growth Opportunities and Forecast Up to 2025
Ultrasonic electrosurgical devices produce less heat, which avoids the charring effect.
-
Long Acting Beta2-Agonists Drugs Market Value Chain Analysis and Forecast up to 2025
Long acting beta2-agonists are used to open narrow airways and prevent asthma attacks
-
Cardioplegia Cannulae Market Comprehensive Analysis and Future Estimations 2025
Cardioplegia Cannulae Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025
-
Single-Cell Analysis Market is Expected to Rise to US$ 6.4 Billion by 2025
Single-Cell Analysis Market report categorizes the global market by Product (Instruments, Consumables)
-
Automated Sample Storage Systems Market will Exhibit a Robust 15.5% CAGR from 2017 - 2025
Automated Sample Storage Systems Market report categorizes the global market by Product Type (System Units and Reagents and Consumables)
-
HER2 Antibodies Market is Estimated to be Worth US$ 21,669.1 Million by 2025
HER2 Antibodies Market report categorizes the global market by Type of Treatment Drugs (Trastuzumab, Lapatinib, Ado-trastuzumab emtansine)
-
Gynecology Hand Instruments Market Key Trends and Opportunity Analysis 2025
Gynecology Hand Instruments Market is driven by ise in awareness about the efficacy of innovative gynecological hand instrument devices among gynecolo
-
Reviewing Vacuum-assisted Fetal Delivery Systems Market: 2017 to 2025
Vacuum-assisted Fetal Delivery Systems Market is driven by Attempts being made to reduce the uterine extension during delivery and the complications a
-
Pressure-Monitoring Kits Market is a Potentially Strong Play Globally
Pressure-Monitoring Kits Market is driven by rising awareness about pet health checkups
-
U.S. Population Health Management Solutions Market Value will Reach to US$ 45.7 Billion by 2023
The population health management solutions market in the U.S. was valued at US$ 3.4 bn in 2014 and is projected to expand at a CAGR of 23.9% from 2015
-
Healthcare Biometrics Market Value will Grow to US$ 5.8 Billion in 2019
Healthcare Biometrics Market is driven due to need for bringing down incidence of healthcare frauds, growing popularity of biometric selfservice in he
-
Healthcare Information Systems Market to Reach a Valuation of US$ 448 Billion by 2024
Healthcare Information Systems Market report categorizes the global market by Application (EHR, EMR, Real-time Healthcare, Population Health Managemen
-
Endoscopy Equipment Market to Rise to a Valuation of More than US$ 33.5 Billion by 2022
Endoscopy Equipment Market report categorizes the global market by Product (Endoscopes, Operative Devices, Visualization Systems)
-
In-Vitro Fertilization Market Value is Projected to Grow to US$ 725.9 Million by the End of 2022
In-Vitro Fertilization Market report categorizes the global market by Product Type (Equipment and Reagents)
-
Contraceptives Market to be Evaluated at US$ 37,242.7 Million by the End of 2025
Contraceptives Market report categorizes the global market by Product
-
Cell Based Assays Market to be Worth US$ 19,710.7 Million by 2022
Cell Based Assays Market report categorizes the global market by Product Type (Instruments, Assay Kits, Reagents and Consumables)
-
Genomics Personalized Health Market is Estimated to Reach US$ 25,112.5 Million by 2025
Genomics Personalized Health Market report categorizes the global market by Technology (NGS platforms, Microarray, and Genetic Analyzers)
-
Microfluidics Market is Estimated to be Worth US$ 12.45 Billion by the End of 2025
Microfluidics Market is estimated to be worth US$12.45 bn by the end of 2025 as compared to US$4.76 bn in 2016.
-
TNF Inhibitors Market Trends with Forecast Up to 2025
TNF inhibitors market can be segmented into etanercept, infliximab, adalimumab, certolizumab, and golimumab.